Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Tuberculosis

Free Subscription Articles published in Emerg Infect Dis Retrieve available abstracts of 56 articles: HTML format

Single Articles

April 2024
1. FUKUNAGA R, Pierre P, Williams JK, Briceno-Robaugh R, et al
   Prioritizing Mental Health within HIV and Tuberculosis Services in PEPFAR.
   Emerg Infect Dis. 2024;30:1-5.
   PubMed     Abstract available
   
   
   
2. DAHL VN, Butova T, Rosenthal A, Grinev A, et al
   Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017-2022.
   Emerg Infect Dis. 2024;30:831-833.
   PubMed     Abstract available
   
   
   
3. GURREY SO, Strick LB, Dov LK, Miller JS, et al
   Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
   Emerg Infect Dis. 2024;30:S17-S20.
   PubMed     Abstract available
   
   
   March 2024
4. SPIES R, Hong HN, Trieu PP, Lan LK, et al
   Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
   Emerg Infect Dis. 2024;30:499-509.
   PubMed     Abstract available
   
   
   
5. GUNTHER G, Mhuulu L, Diergaardt A, Dreyer V, et al
   Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
   Emerg Infect Dis. 2024;30:568-571.
   PubMed     Abstract available
   
   
   January 2024
6. HAN E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, et al
   Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020.
   Emerg Infect Dis. 2024;30:136-140.
   PubMed     Abstract available
   
   
   
7. HUMAYUN M, Mukasa L, Ye W, Bates JH, et al
   Racial and Ethnic Disparities in Tuberculosis Incidence, Arkansas, USA, 2010-2021.
   Emerg Infect Dis. 2024;30:116-124.
   PubMed     Abstract available
   
   
   
8. NSENGIYUMVA NP, Khan A, Gler MMTS, Tonquin ML, et al
   Costs of Digital Adherence Technologies for Tuberculosis Treatment Support, 2018-2021.
   Emerg Infect Dis. 2024;30:79-88.
   PubMed     Abstract available
   
   
   December 2023
9. LAFLEUR M, Rasoanaivo HA, Andrianarivo TH, Andrianomanana FR, et al
   Tuberculosis in Lemurs and a Fossa at National Zoo, Madagascar, 2022.
   Emerg Infect Dis. 2023;29:2587-2589.
   PubMed     Abstract available
   
   
   November 2023
10. MODONGO C, Barilar I, Wang Q, Molefi T, et al
    Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana.
    Emerg Infect Dis. 2023;29:2403-2406.
    PubMed     Abstract available
    
    
    October 2023
11. WINSTON CA, Marks SM, Carr W
    Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States.
    Emerg Infect Dis. 2023;29:2102-2104.
    PubMed     Abstract available
    
    
    August 2023
12. NABITY SA, Marks SM, Goswami ND, Smith SR, et al
    Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available
    
    
    
13. LOUIE JK, Agraz-Lara R, Romo L, Deiterich C, et al
    Uniting for Ukraine Tuberculosis Screening Experience, San Francisco, California, USA.
    Emerg Infect Dis. 2023;29:1651-1654.
    PubMed     Abstract available
    
    
    July 2023
14. WOODRUFF R, Miramontes R
    Tuberculosis Infection among Non-US-Born Persons and Persons >/=60 Years of Age, United States, 2019-2020.
    Emerg Infect Dis. 2023;29:1470-1472.
    PubMed     Abstract available
    
    
    May 2023
15. NOROC E, Chesov D, Merker M, Groschel MI, et al
    Limited Nosocomial Transmission of Drug-Resistant Tuberculosis, Moldova.
    Emerg Infect Dis. 2023;29:1046-1050.
    PubMed     Abstract available
    
    
    
16. NGUYEN HV, Brals D, Tiemersma E, Gasior R, et al
    Influence of Sex and Sex-Based Disparities on Prevalent Tuberculosis, Vietnam, 2017-2018.
    Emerg Infect Dis. 2023;29:967-976.
    PubMed     Abstract available
    
    
    
17. BAKER CR, Barilar I, de Araujo LS, Rimoin AW, et al
    Use of High-Resolution Geospatial and Genomic Data to Characterize Recent Tuberculosis Transmission, Botswana.
    Emerg Infect Dis. 2023;29:977-987.
    PubMed     Abstract available
    
    
    
18. MILLARD J, Rimmer S, Nimmo C, O'Donnell M, et al
    Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB.
    Emerg Infect Dis. 2023;29:1081-1084.
    PubMed     Abstract available
    
    
    March 2023
19. SHARMA M, Mathesh K, Dandapat P, Mariappan AK, et al
    Emergence of Mycobacterium orygis-Associated Tuberculosis in Wild Ruminants, India.
    Emerg Infect Dis. 2023;29:661-663.
    PubMed     Abstract available
    
    
    
20. LUKOYE D, Gustavson G, Namuwenge PM, Muchuro S, et al
    Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016-2022.
    Emerg Infect Dis. 2023;29:609-613.
    PubMed     Abstract available
    
    
    
21. MIYAHARA R, Piboonsiri P, Chiyasirinroje B, Imsanguan W, et al
    Risk for Prison-to-Community Tuberculosis Transmission, Thailand, 2017-2020.
    Emerg Infect Dis. 2023;29:477-483.
    PubMed     Abstract available
    
    
    
22. MEESAWAT S, Warit S, Hamada Y, Malaivijitnond S, et al
    Prevalence of Mycobacterium tuberculosis Complex among Wild Rhesus Macaques and 2 Subspecies of Long-Tailed Macaques, Thailand, 2018-2022.
    Emerg Infect Dis. 2023;29:551-560.
    PubMed     Abstract available
    
    
    December 2022
23. IHEKWEAZU C
    Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:S299-S301.
    PubMed     Abstract available
    
    
    September 2022
24. KHERABI Y, Frechet-Jachym M, Rioux C, Yazdanpanah Y, et al
    Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006-2019.
    Emerg Infect Dis. 2022;28:1796-1804.
    PubMed     Abstract available
    
    
    
25. CAMPBELL JR, Nsengiyumva P, Chiang LY, Jamieson F, et al
    Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010-2016.
    Emerg Infect Dis. 2022;28:1814-1823.
    PubMed     Abstract available
    
    
    
26. LAEMMLE-RUFF I, Graham SM, Williams B, Horyniak D, et al
    Detecting Mycobacterium tuberculosis Infection in Children Migrating to Australia.
    Emerg Infect Dis. 2022;28:1833-1841.
    PubMed     Abstract available
    
    
    July 2022
27. SHEA J, Smith C, Halse TA, Kohlerschmidt D, et al
    Novel Mycobacterium tuberculosis Complex Genotype Related to M. caprae.
    Emerg Infect Dis. 2022;28:1431-1436.
    PubMed     Abstract available
    
    
    May 2022
28. LE RAY LF, Aubry A, Sougakoff W, Revest M, et al
    atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure.
    Emerg Infect Dis. 2022;28:1062-1064.
    PubMed     Abstract available
    
    
    April 2022
29. WINGLEE K, Hill AN, Langer AJ, Self JL, et al
    Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020.
    Emerg Infect Dis. 2022;28:820-827.
    PubMed     Abstract available
    
    
    March 2022
30. HASAN T, Nguyen VN, Nguyen HB, Nguyen TA, et al
    Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.
    Emerg Infect Dis. 2022;28:684-692.
    PubMed     Abstract available
    
    
    
31. KHAN A, Phares CR, Phuong HL, Trinh DTK, et al
    Overseas Treatment of Latent Tuberculosis Infection in US-Bound Immigrants.
    Emerg Infect Dis. 2022;28:582-590.
    PubMed     Abstract available
    
    
    
32. NATAPRAWIRA HM, Gafar F, Risan NA, Wulandari DA, et al
    Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia.
    Emerg Infect Dis. 2022;28:660-671.
    PubMed     Abstract available
    
    
    November 2021
33. AUNG HL, Nyunt WW, Fong Y, Biggs PJ, et al
    Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar.
    Emerg Infect Dis. 2021;27:2847-2855.
    PubMed     Abstract available
    
    
    August 2021
34. PAPAVENTSIS D, Dougas G, Kalkouni O, Karabela S, et al
    Occupational Exposure to Zoonotic Tuberculosis Caused by Mycobacterium caprae, Northern Greece, 2019.
    Emerg Infect Dis. 2021;27:1997-1999.
    PubMed     Abstract available
    
    
    
35. LOUIE JK, Agraz-Lara R, Romo L, Crespin F, et al
    Tuberculosis-Associated Hospitalizations and Deaths after COVID-19 Shelter-In-Place, San Francisco, California, USA.
    Emerg Infect Dis. 2021;27:2227-2229.
    PubMed     Abstract available
    
    
    
36. GHIELMETTI G, Kupca AM, Hanczaruk M, Friedel U, et al
    Mycobacterium microti Infections in Free-Ranging Red Deer (Cervus elaphus).
    Emerg Infect Dis. 2021;27:2025-2032.
    PubMed     Abstract available
    
    
    July 2021
37. SOKO RN, Burke RM, Feasey HRA, Sibande W, et al
    Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.
    Emerg Infect Dis. 2021;27:1831-1839.
    PubMed     Abstract available
    
    
    June 2021
38. TALWAR A, Li R, Langer AJ
    Association between Birth Region and Time to Tuberculosis Diagnosis among Non-US-Born Persons in the United States.
    Emerg Infect Dis. 2021;27:1645-1653.
    PubMed     Abstract available
    
    
    April 2021
39. DE VAL BP, Romero B, Tortola MT, Leon LH, et al
    Polyresistant Mycobacterium bovis Infection in Human and Sympatric Sheep, Spain, 2017-2018.
    Emerg Infect Dis. 2021;27:1241-1243.
    PubMed     Abstract available
    
    
    March 2021
40. MALIK AA, Gandhi NR, Lash TL, Cranmer LM, et al
    Effectiveness of Preventive Therapy for Persons Exposed at Home to Drug-Resistant Tuberculosis, Karachi, Pakistan.
    Emerg Infect Dis. 2021;27:805-812.
    PubMed    
    
    
    
41. LAFLEUR M, Reuter KE, Hall MB, Rasoanaivo HH, et al
    Drug-Resistant Tuberculosis in Pet Ring-Tailed Lemur, Madagascar.
    Emerg Infect Dis. 2021;27:977-979.
    PubMed     Abstract available
    
    
    
42. WALTER KS, Tatara MB, Esther da Silva K, Moreira FMF, et al
    Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil, 2014-2017.
    Emerg Infect Dis. 2021;27:905-914.
    PubMed     Abstract available
    
    
    
43. NGUYEN HV, Nguyen HB, Nguyen NV, Cobelens F, et al
    Decline of Tuberculosis Burden in Vietnam Measured by Consecutive National Surveys, 2007-2017.
    Emerg Infect Dis. 2021;27:872-879.
    PubMed     Abstract available
    
    
    
44. FAROOQ HZ, Cirillo DM, Hillemann D, Wyllie D, et al
    Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs.
    Emerg Infect Dis. 2021;27:985-987.
    PubMed     Abstract available
    
    
    
45. NONGHANPHITHAK D, Chaiprasert A, Smithtikarn S, Kamolwat P, et al
    Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014-2017.
    Emerg Infect Dis. 2021;27:813-822.
    PubMed     Abstract available
    
    
    
46. CUEVAS LE, Santos VS, Lima SVMA, Kontogianni K, et al
    Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB/RIF Tuberculosis Testing during the COVID-19 Pandemic.
    Emerg Infect Dis. 2021;27:719-727.
    PubMed     Abstract available
    
    
    
47. ZETOLA NM, Moonan PK, Click E, Oeltmann JE, et al
    Population-Based Geospatial and Molecular Epidemiologic Study of Tuberculosis Transmission Dynamics, Botswana, 2012-2016.
    Emerg Infect Dis. 2021;27:835-844.
    PubMed     Abstract available
    
    
    
48. TAZERART F, Saad J, Niar A, Sahraoui N, et al
    Mycobacterium bovis Pulmonary Tuberculosis, Algeria.
    Emerg Infect Dis. 2021;27:972-974.
    PubMed     Abstract available
    
    
    
49. CHITWOOD MH, Pelissari DM, Marques da Silva GD, Bartholomay P, et al
    Trends in Untreated Tuberculosis in Large Municipalities, Brazil, 2008-2017.
    Emerg Infect Dis. 2021;27:957-960.
    PubMed     Abstract available
    
    
    
50. MILLER MA, Kerr TJ, de Waal CR, Goosen WJ, et al
    Mycobacterium bovis Infection in Free-Ranging African Elephants.
    Emerg Infect Dis. 2021;27:990-992.
    PubMed     Abstract available
    
    
    January 2021
51. LEAVITT SV, Jacobson KR, Ragan EJ, Bor J, et al
    Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa.
    Emerg Infect Dis. 2021;27:728-739.
    PubMed     Abstract available
    
    
    December 2020
52. MANDALAKAS AM, Kay AW, Bacha JM, Devezin T, et al
    Tuberculosis among Children and Adolescents at HIV Treatment Centers in Sub-Saharan Africa.
    Emerg Infect Dis. 2020;26.
    PubMed    
    
    
    November 2020
53. HALEY CA, Macias P, Jasuja S, Jones BA, et al
    Novel 6-Month Treatment for Drug-Resistant Tuberculosis, United States.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available
    
    
    
54. HOPEWELL PC, Reichman LB, Castro KG
    Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available
    
    
    March 2020
55. KERR TJ, Gumbo R, Goosen WJ, Rogers P, et al
    Novel Techniques for Detection of Mycobacterium bovis Infection in a Cheetah.
    Emerg Infect Dis. 2020;26:630-631.
    PubMed     Abstract available
    
    
    
56. POORANSINGH S, Sakhamuri S
    Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations.
    Emerg Infect Dis. 2020;26:624-625.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.